Literature DB >> 17884631

Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.

Jinghua Chen1, Courtney L Jones, Jian Liu.   

Abstract

Heparan sulfate (HS) represents a major class of glycans that perform central physiological functions. Emerging HS and glycosaminoglycan microarray techniques are used to interrogate the structure and function relationship to develop novel therapeutic agents. Availability of HS with specific sulfation patterns has been a limiting factor and impedes the accuracy of HS glycomics studies. Although organic synthesis provides oligosaccharides, these may not fully represent the biological functions of polysaccharides. Here, we present a study for developing an enzyme-based approach to synthesize a polysaccharide library with different sulfation patterns. Using different combinations of biosynthetic enzymes, we synthesized eight unique polysaccharides. We discovered that polysaccharides without the iduronic acid residue displayed strong binding affinity to antithrombin and high anti-Xa and anti-IIa activities. The enzyme-based synthetic approach could become a general method for discovering new HS structures with unique biological functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884631      PMCID: PMC4809194          DOI: 10.1016/j.chembiol.2007.07.015

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  35 in total

Review 1.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Sulfation patterns of glycosaminoglycans encode molecular recognition and activity.

Authors:  Cristal I Gama; Sarah E Tully; Naoki Sotogaku; Peter M Clark; Manish Rawat; Nagarajan Vaidehi; William A Goddard; Akinori Nishi; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2006-07-30       Impact factor: 15.040

3.  Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides.

Authors:  M D Burkart; M Izumi; E Chapman; C H Lin; C H Wong
Journal:  J Org Chem       Date:  2000-09-08       Impact factor: 4.354

4.  Affinity, kinetic, and structural study of the interaction of 3-O-sulfotransferase isoform 1 with heparan sulfate.

Authors:  Eva Muñoz; Ding Xu; Melissa Kemp; Fuming Zhang; Jian Liu; Robert J Linhardt
Journal:  Biochemistry       Date:  2006-04-25       Impact factor: 3.162

5.  Contribution of monosaccharide residues in heparin binding to antithrombin III.

Authors:  D H Atha; J C Lormeau; M Petitou; R D Rosenberg; J Choay
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

6.  The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5.

Authors:  Michael B Duncan; Jinghua Chen; Jeffrey P Krise; Jian Liu
Journal:  Biochim Biophys Acta       Date:  2004-03-17

7.  Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue.

Authors:  S Björnsson
Journal:  Anal Biochem       Date:  1993-05-01       Impact factor: 3.365

8.  Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide.

Authors:  Balagurunathan Kuberan; Miroslaw Z Lech; David L Beeler; Zhengliang L Wu; Robert D Rosenberg
Journal:  Nat Biotechnol       Date:  2003-10-05       Impact factor: 54.908

9.  Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5.

Authors:  Jinghua Chen; Michael B Duncan; Kevin Carrick; R Marshall Pope; Jian Liu
Journal:  Glycobiology       Date:  2003-08-07       Impact factor: 4.313

Review 10.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

View more
  53 in total

1.  Structural characterization of heparins from different commercial sources.

Authors:  Fuming Zhang; Bo Yang; Mellisa Ly; Kemal Solakyildirim; Zhongping Xiao; Zhenyu Wang; Julie M Beaudet; Amanda Y Torelli; Jonathan S Dordick; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2011-09-20       Impact factor: 4.142

2.  Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach.

Authors:  Yongmei Xu; Zhen Wang; Renpeng Liu; Arlene S Bridges; Xuefei Huang; Jian Liu
Journal:  Glycobiology       Date:  2011-08-11       Impact factor: 4.313

3.  Chemoenzymatic design of heparan sulfate oligosaccharides.

Authors:  Renpeng Liu; Yongmei Xu; Miao Chen; Michel Weïwer; Xianxuan Zhou; Arlene S Bridges; Paul L DeAngelis; Qisheng Zhang; Robert J Linhardt; Jian Liu
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

4.  Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities.

Authors:  Yongmei Xu; Elizabeth H Pempe; Jian Liu
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

5.  Cyclic AMP (cAMP) Receptor Protein-cAMP Complex Regulates Heparosan Production in Escherichia coli Strain Nissle 1917.

Authors:  Huihui Yan; Feifei Bao; Liping Zhao; Yanying Yu; Jiaqin Tang; Xianxuan Zhou
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

6.  Combinatorial enzymatic synthesis of heparan sulfate.

Authors:  Robert J Linhardt; Jin-Hwan Kim
Journal:  Chem Biol       Date:  2007-09

7.  Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.

Authors:  Ronald Copeland; Arun Balasubramaniam; Vaibhav Tiwari; Fuming Zhang; Arlene Bridges; Robert J Linhardt; Deepak Shukla; Jian Liu
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

8.  Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

Authors:  Sailaja Arungundram; Kanar Al-Mafraji; Jinkeng Asong; Franklin E Leach; I Jonathan Amster; Andre Venot; Jeremy E Turnbull; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

9.  Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.

Authors:  Y Buyue; T M Misenheimer; J P Sheehan
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

10.  Molecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase.

Authors:  Chunhui Liu; Juzheng Sheng; Juno M Krahn; Lalith Perera; Yongmei Xu; Po-Hung Hsieh; Wenfang Dou; Jian Liu; Lars C Pedersen
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.